MiR-122 targets SerpinB3 and is involved in Sorafenib resistance in hepatocellular carcinoma. Issue 1 (16th February 2017) - Pollutri, D.; Fornari, F.; Turato, C.; Villano, G.; Quarta, S.; Ruvoletto, M.; Bolondi, L.; Gramantieri, L.; Pontisso, P.